Compounds > 5,7-dihydroxytryptamine
Page last updated: 2024-08-23

5,7-dihydroxytryptamine and alaproclate

5,7-dihydroxytryptamine has been researched along with alaproclate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodin, E; Franck, J; Rosén, A1
Goldstein, DS; Kopin, IJ; Pacak, K; Yadid, G1

Other Studies

2 other study(ies) available for 5,7-dihydroxytryptamine and alaproclate

ArticleYear
Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey.
    Neuropeptides, 1995, Volume: 28, Issue:6

    Topics: 5,7-Dihydroxytryptamine; Alanine; Animals; Cholecystokinin; Kinetics; Male; Morphine; Neurokinin A; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance P

1995
Endogenous serotonin stimulates striatal dopamine release in conscious rats.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: 5,7-Dihydroxytryptamine; Alanine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Male; Microdialysis; Perfusion; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists

1994